GlassScriptPhysician profile
Nathan P Carr
NPI 1215160460
$1,710.09
in general payments reported to CMS, 2019-2025
19 companies · $810 in 2025
The $810 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.91 · 2022: $117 · 2023: $98.92 · 2024: $673 · 2025: $810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,065 · Consulting Fee: $350 · Education: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,064.56 |
| Consulting Fee | $350.00 |
| Education | $166.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avadel Cns Pharmaceuticals, LLC | $553.24 | 2024-2025 | Lumryz |
| Jazz Pharmaceuticals INC. | $401.57 | 2022-2025 | |
| Inspire Medical Systems, INC. | $195.78 | 2023-2025 | Inspire |
| Harmony Biosciences LLC | $99.99 | 2025 | |
| Fisher & Paykel Healthcare INC | $79.14 | 2024-2025 | Fisher & Paykel Healthcare |
| Lilly USA, LLC | $71.24 | 2025 | Mounjaro, Zepbound, Jardiance |
| Tandem Diabetes Care, INC. | $47.77 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Bayer Healthcare Pharmaceuticals INC. | $34.00 | 2024 | |
| Insulet Corporation | $32.52 | 2024 | Omnipod |
| Nevro Corp. | $30.34 | 2024 | Senza |
| Recordati_rare_diseases_inc. | $23.07 | 2025 | Isturisa |
| Abbott Laboratories | $22.55 | 2025 | Freestyle Libre 3 |
| Dexcom, INC. | $20.27 | 2024 | Dexcom G6 Transmitter |
| Antares Pharma, INC. | $19.86 | 2024 | Xyosted |
| Novo Nordisk INC | $19.80 | 2024 | Wegovy |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $17.76 | 2024 | Evenity, Prolia |
| Ibsa Pharma INC. | $15.57 | 2024 | Licart, Tirosint |
| Cequr Corporation | $13.71 | 2025 | Cequr Simplicity |
| Janssen Pharmaceuticals, INC | $11.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.